Skip to content
  • Career
  • Support
  • Contact Us
Menu
  • Career
  • Support
  • Contact Us
  • Solutions
    • Clinical Services
    • Research Services
  • Get Started
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
Menu
  • Solutions
    • Clinical Services
    • Research Services
  • Get Started
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
Search
Close
Menu
  • Solutions
    • Clinical Services
    • Research Services
  • Get Started
    • Get a Quote
    • Get Set Up
  • News & Events
    • News
    • Events
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
  • Career
  • Support
  • Contact Us
  • All posts

MRI Study Targets Biomarkers for Diabetes Mellitus

  • December 1, 2016

SSQ06-02, Room E350; 1 December 2016 – Researchers from Sweden are using MRI to profile the body composition of people with diabetes mellitus to provide direct biomarkers and improve characterization and early diagnosis of the disease.

“These metrics of body composition are believed to be associated with the risk of developing diabetes and/or comorbidities and complications,” wrote Olof Dahlqvist Leinhard, PhD, from Linköping University, in an email to AuntMinnie.com. “The study provides a deeper understanding of the clinical presentation of people with or at high risk of developing diabetes mellitus.”

Leinhard and colleagues reviewed the first 3,900 subjects in the U.K. Biobank Imaging Study to compare people with diabetes mellitus to those without and identify normative values for body composition and ectopic fat storage. Subjects underwent 1.5-tesla MRI scans using a Dixon imaging protocol from the neck to knee and a 10-point Dixon single-axial slice protocol positioned in the liver.

The results led the researchers to conclude that diabetes mellitus is strongly associated with high visceral fat, liver fat, and total abdominal fat, as well as a low muscle ratio.

“Most methods that measure body fat, such as hydrostatic weighing and air displacement plethysmography, are not able to differentiate between ectopic fat compartments or provide accurate, precise quantification of visceral fat,” Leinhard said. “MRI, as well as being the gold standard in 3D volumetric imaging of adipose tissue and muscle tissue, provides accurate and precise measures of all three biomarkers — visceral fat, liver fat, and muscle fat — and all through one six-minute scan.”

The next step in the research is to define and validate predictive risk values and use these risk profiles to determine the best personalized treatment regimens, he said.

The investigation is also part of a larger study in which 100,000 subjects from U.K. Biobank will be scanned to quantify values for visceral adipose tissue volume, total abdominal adipose tissue volume, total lean thigh muscle volume, and liver proton density fat fraction.

By Wayne Forrest, AuntMinnie.com staff writer

  • All posts
Follow us
Linkedin Twitter Facebook

About

AMRA offers clinical services and research services to support transformative care and vital decision-making, from clinical research to clinical care.

Contact

  • info@amramedical.com
  • +46 (0) 13 16 26 00
  • Contact Our Support
  • Data Privacy Policy
  • Cookie Policy
  • Data Privacy Policy
  • Cookie Policy

Newsletter

    © 2023 AMRA Medical AB

    AMRA Medical
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View preferences
    {title} {title} {title}
    AMRA Medical
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View preferences
    {title} {title} {title}